Tien Liang BioTech Co., Ltd. (4127.TWO)

TWD 37.4

(5.65%)

EBITDA Summary of Tien Liang BioTech Co., Ltd.

  • Tien Liang BioTech Co., Ltd.'s latest annual EBITDA in 2023 was 31.04 Million TWD , down -59.13% from previous year.
  • Tien Liang BioTech Co., Ltd.'s latest quarterly EBITDA in 2024 Q2 was -331 Thousand TWD , down -103.26% from previous quarter.
  • Tien Liang BioTech Co., Ltd. reported an annual EBITDA of 72.14 Million TWD in 2022, up 14.41% from previous year.
  • Tien Liang BioTech Co., Ltd. reported an annual EBITDA of 63.06 Million TWD in 2021, up 298.39% from previous year.
  • Tien Liang BioTech Co., Ltd. reported a quarterly EBITDA of -331 Thousand TWD for 2024 Q2, down -103.26% from previous quarter.
  • Tien Liang BioTech Co., Ltd. reported a quarterly EBITDA of 11.44 Million TWD for 2023 Q4, up 555.59% from previous quarter.

Annual EBITDA Chart of Tien Liang BioTech Co., Ltd. (2023 - 2019)

Historical Annual EBITDA of Tien Liang BioTech Co., Ltd. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 31.04 Million TWD -59.13%
2022 72.14 Million TWD 14.41%
2021 63.06 Million TWD 298.39%
2020 -31.78 Million TWD -47.46%
2019 -21.55 Million TWD 0.0%

Peer EBITDA Comparison of Tien Liang BioTech Co., Ltd.

Name EBITDA EBITDA Difference
Allied Biotech Corporation 204.79 Million TWD 84.839%
GeneFerm Biotechnology Co., Ltd. 231.09 Million TWD 86.565%
Easywell Biomedicals, Inc. -85.5 Million TWD 136.313%
TTY Biopharm Company Limited 1.52 Billion TWD 97.963%
Synmosa Biopharma Corporation 1 Billion TWD 96.922%
Orient EuroPharma Co., Ltd. 582.93 Million TWD 94.674%
Center Laboratories, Inc. -175.17 Million TWD 117.724%
Orient Pharma Co., Ltd. 172.39 Million TWD 81.99%
InnoPharmax Inc. -62.12 Million TWD 149.981%
Johnson Chemical Pharmaceutical Works Co., Ltd. 126.67 Million TWD 75.491%
Excelsior Biopharma Inc. -29.36 Million TWD 205.717%
DV Biomed Co., Ltd. 407.64 Million TWD 92.383%
Foresee Pharmaceuticals Co., Ltd. -912.16 Million TWD 103.404%
Handa Pharmaceuticals, Inc. 802.78 Million TWD 96.132%
UniPharma Co., Ltd. -16.25 Million TWD 291.018%
Anxo Pharmaceutical Co., Ltd. 131.31 Million TWD 76.355%
Alar Pharmaceuticals Inc. 394.52 Million TWD 92.13%
Winston Medical Supply Co., Ltd. 228.32 Million TWD 86.402%
Mercury Biopharmaceutical Corporation -39.03 Million TWD 179.541%
Bioray Biotech Co., Ltd 12.13 Million TWD -155.855%
TSH Biopharm Corporation Limited 99.35 Million TWD 68.749%